Gregory S. Naeve PhD

Greg is currently the Sr. Director of Pfizer’s San Francisco office for Strategic Research Partnerships in the External Research, Development, & Innovation group. Most recently he worked for The Column Group, a San Francisco-based life science venture fund focused on investing in early stage therapeutic opportunities. Prior to that he was the President and Chief Scientific Officer of Parallax Biosystems, a company he co-founded to develop novel molecular detection platforms with applications in pre-clinical drug discovery and diagnostics. Before Parallax he held positions at Neurocrine Biosciences and Amgen working to develop new therapies for neurodegenerative disorders. He received his Ph.D. in Biochemistry from the University of Southern California.